BRIEF published on 08/15/2025 at 07:35, 8 months 20 days ago Sensorion Renforce son Contrat de Liquidité avec Kepler Cheuvreux Euronext Biotechnologie Kepler Cheuvreux Liquidité Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 8 months 20 days ago Inside Information / Other news releases Sensorion increases resources allocated to liquidity contract with Kepler Cheuvreux by €60,000 to enhance liquidity of shares on Euronext Paris. The move is in accordance with AMF Decision No. 2021-01 Euronext Paris Liquidity Contract Kepler Cheuvreux AMF Decision Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 8 months 20 days ago Informations privilégiées / Autres communiqués Sensorion augmente les moyens du contrat de liquidité avec Kepler Cheuvreux conformément à la décision de l'AMF. Détails des actions et du montant ajouté Biotechnologie Kepler Cheuvreux Liquidité AMF Sensorion
BRIEF published on 07/31/2025 at 09:22, 9 months 4 days ago Sensorion Announces Participation in Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Therapies September-October 2025
BRIEF published on 07/31/2025 at 09:22, 9 months 4 days ago Sensorion annonce sa participation à des conférences d'investisseurs Biotechnologie Conférences Investisseurs Sensorion Thérapies Auditives Septembre-Octobre 2025
PRESS RELEASE published on 07/31/2025 at 09:17, 9 months 4 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs à venir en septembre et octobre 2025. La société présentera ses avancées dans le domaine de la biotechnologie et des thérapies pour la perte auditive Biotechnologie Conférences Investisseurs Sensorion Perte Auditive Thérapies Auditives
BRIEF published on 07/01/2025 at 07:35, 10 months 3 days ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
BRIEF published on 07/01/2025 at 07:35, 10 months 3 days ago Sensorion publie des données préliminaires positives issues de l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion SENS-501 Surdité Congénitale Essai Audiogene
PRESS RELEASE published on 07/01/2025 at 07:30, 10 months 3 days ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 10 months 3 days ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
Published on 05/04/2026 at 20:45, 1 hour 1 minute ago Silver Spruce Resources Inc. Announces Change to Director Slate for Annual General and Special Meeting of Shareholders
Published on 05/04/2026 at 16:45, 5 hours 1 minute ago Inventus Announces Engagement of Red Cloud Securities
Published on 05/04/2026 at 16:27, 5 hours 19 minutes ago Avenir Minerals to Acquire Fox River Resources in All-Cash Transaction for Approximately C$94.3 Million
Published on 05/04/2026 at 15:30, 6 hours 16 minutes ago Silver Spruce Resources Announces Resumption of Exploration at its Melchett Lake Au-Ag-Zn-Pb-Cu Volcanogenic Massive Sulphide Project, Nakina, Ontario
Published on 05/04/2026 at 15:00, 6 hours 46 minutes ago Shelfie Signs Definitive Agreement to Acquire Majority Interest in Israeli Based Aspect Information Systems Ltd.
Published on 05/04/2026 at 21:05, 41 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for Q1 2026 of €47.9 million and adjusted EBITDA of €7.6 million; forecast for the continuing operations unchanged
Published on 05/04/2026 at 20:02, 1 hour 43 minutes ago EQS-Adhoc: Rheinmetall AG: Preliminary operating margin in line with market expectation; revenue below market expectation despite growth due to delays into Q2 – 2026 full-year forecast reaffirmed
Published on 05/04/2026 at 19:30, 2 hours 16 minutes ago Shareholders approve all proposals – Dr Annelise Lüscher Hämmerli and Urs Simeon elected to the Board of Directors
Published on 05/04/2026 at 19:00, 2 hours 46 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 27 AVRIL 2026 au 01 MAI 2026
Published on 05/04/2026 at 19:00, 2 hours 46 minutes ago L’Assemblée générale 2026 approuve toutes les propositions du Conseil d’administration
Published on 05/04/2026 at 20:57, 49 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 05/04/2026 at 20:57, 49 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 05/04/2026 at 20:06, 1 hour 40 minutes ago Avril 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 05/04/2026 at 19:05, 2 hours 41 minutes ago CP -Mise en œuvre d’un contrat de liquidité avec INVEST SECURITIES
Published on 05/04/2026 at 18:19, 3 hours 27 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
